Project Grant 2035422
Award Date
2/15/21
Completion Date
1/31/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Awardee
Eradivir Inc. (QGDJNUMU9VR6)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
The National Science Foundation awarded a $255,981 Small Business Innovation Research Phase I Project Grant to Frezent Biological Solutions Inc. of Valhalla, NY under the Engineering (CFDA 47.041) federal grant program. The grant funds the development of a novel peptide inhibitor of the coronavirus papain-like protease as a prophylactic and antiviral therapeutic for COVID-19, to be administered via inhalation. The Engineering program seeks to improve quality of life and economic strength...
Spirrow Therapeutics LLC received a $256,000 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation under the Engineering program (CFDA 47.041) to develop polymer surfactant therapy for acute respiratory distress syndrome (ARDS), including that caused by COVID-19. The grant period runs from February 15, 2021 through January 31, 2022. The NSF Engineering program seeks to improve quality of life and economic strength through engineering research and...
Paramita Therapeutics Inc. received a $255,990 National Science Foundation SBIR Phase I Project Grant to develop a novel Covid-19 dual-function therapeutic/vaccine product. The grant was awarded on May 1, 2021 under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support research and innovation leading to breakthrough technologies and solutions to national challenges. The project aims to advance science and engineering related to the Covid-19 pandemic through the...
This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
Nellone Therapeutics Inc. received a $242k National Science Foundation SBIR Phase I Project Grant under the Engineering federal grant program to develop regulation of hyperinflammation and cell survival therapies for severe lung tissue damage from viral infections such as COVID-19. The award period is April 1, 2021 through March 31, 2022. As part of NSF's mission to promote innovation and U.S. competitiveness, this SBIR Phase I grant supports Nellone's proposed research to advance a NELL1/NV1...
The National Science Foundation Division of Industrial Innovation awarded a $255,908 Project Grant to Verisim Life, Inc. under the Engineering (47.041) federal grant program. The grant supports Verisim Life's efforts to rapidly repurpose and translate COVID-19 therapeutics using an AI-based biosimulation platform. Specifically, the company will apply its platform to research multi-target therapies involving angiotensin-converting enzyme 2 and calcium pathways, which could help combat the...
Altigg Therapeutics, Inc. was awarded a $255,595 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation's Engineering program (CFDA 47.041) for the period of April 1, 2021 through March 31, 2022. Under this award, Altigg Therapeutics will develop a platform for the rapid discovery of human antibodies as therapeutics for infectious diseases such as COVID-19. The NSF Engineering program seeks to improve quality of life and economic strength through...